Galectin Therapeutics
GALT
$3.23
Share price
2.87%
Change (1 day)
93.41%
Change (1 year)
Categories
Galectin Therapeutics (GALT) - Total liabilities
Total liabilities on the balance sheet as of December 2023 : $88.44 M
According to Galectin Therapeutics's latest financial reports the company's total liabilities are $88.44 M. A company’s total liabilities is the sum of all current and non-current debts and obligations.
Galectin Therapeutics - Total liabilities on balance sheet (from 2001 to 2023)
Total liabilities by year
| Year | Total liabilities | Change |
|---|---|---|
| 2022-12-31 | $53.47 M | 36.39% |
| 2021-12-31 | $39.21 M | 625.19% |
| 2020-12-31 | $5.4 M | 88.27% |
| 2019-12-31 | $2.87 M | 36.24% |
| 2018-12-31 | $2.1 M | -28.98% |
| 2017-12-31 | $2.96 M | -21.48% |
| 2016-12-31 | $3.78 M | 177.94% |
| 2015-12-31 | $1.36 M | -20.14% |
| 2014-12-31 | $1.7 M | -31.5% |
| 2013-12-31 | $2.48 M | 51.22% |
| 2012-12-31 | $1.64 M | -25.78% |
| 2011-12-31 | $2.21 M | -72.29% |
| 2010-12-31 | $7.99 M | 63.04% |
| 2009-12-31 | $4.9 M | 317.99% |
| 2008-12-31 | $1.17 M | -75.07% |
| 2007-12-31 | $4.7 M | -26.3% |
| 2006-12-31 | $6.38 M | 362.68% |
| 2005-12-31 | $1.38 M | 37.31% |
| 2004-12-31 | $1 M | 165.87% |
| 2003-12-31 | $0.37 M | -43.31% |
| 2002-12-31 | $0.66 M | 21.08% |
| 2001-12-31 | $0.55 M |
Total liabilities for similar companies or competitors
| Company | Total liabilities | differencediff. | Country |
|---|---|---|---|
 Mirati Therapeutics MRTX | $0.18 B | 107.19% | 🇺🇸 USA |
 MannKind Corp MNKD | $0.72 B | 715.65% | 🇺🇸 USA |